<DOC>
	<DOCNO>NCT01062282</DOCNO>
	<brief_summary>The purpose study gain information safety efficacy Korean patient start Ventavis treatment observational method .</brief_summary>
	<brief_title>Hypertension Study VentavisÂ® Inhalation Therapy Treatment Patients With Pulmonary Arterial Hypertension ( VENIS )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Iloprost</mesh_term>
	<criteria>The treat physician chosen Ventavis suitable treatment patient Patient PH classify NYHA functional class III IV WHO group 1 Any condition prevents participation study , include pregnancy contraindication Ventavis treatment ( list current Ventavis patient package insert ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Pulmonary Hypertension</keyword>
</DOC>